Androgens, cardiovascular risk factors and atherosclerosis

[1]  A. von Eckardstein,et al.  Effects of testosterone suppression in young men by the gonadotropin releasing hormone antagonist cetrorelix on plasma lipids, lipolytic enzymes, lipid transfer proteins, insulin, and leptin. , 2009, Experimental and clinical endocrinology & diabetes.

[2]  B. Angelin,et al.  Therapy for lowering lipoprotein (a) levels. , 1997, Current opinion in lipidology.

[3]  N. Benda,et al.  Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[4]  G. Schmitz,et al.  Scavenging, signalling and adhesion coupling in macrophages: implications for atherogenesis , 1997, Current opinion in lipidology.

[5]  I. Tabas.  Phospholipid metabolism in cholesterol-loaded macrophages , 1997, Current opinion in lipidology.

[6]  S. Rw.  Effects of estrogens on macrophage foam cells: a potential target for the protective effects of estrogens on atherosclerosis. , 1997 .

[7]  A. von Eckardstein,et al.  Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a). , 1997, The Journal of clinical endocrinology and metabolism.

[8]  D. Celermajer,et al.  Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[9]  C. Bouchard,et al.  Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables. , 1997, Atherosclerosis.

[10]  Rudolph L. Leibel,et al.  Medical progress: Obesity. , 1997 .

[11]  E. Nieschlag,et al.  Strong association between serum levels of leptin and testosterone in men , 1997, Clinical endocrinology.

[12]  R. Knopp,et al.  17beta-Estradiol, progesterone, and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages. , 1997, American journal of obstetrics and gynecology.

[13]  K. Polonsky,et al.  Troglitazone Improves Defects in Insulin Action , Insulin Secretion , Ovarian Steroidogenesis , and Fibrinolysis in Women with Polycystic Ovary Syndrome * , 1997 .

[14]  R. Rosenson,et al.  Lipoprotein Lp(a) excess and coronary heart disease. , 1997, Archives of internal medicine.

[15]  S. Yen,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Serum Leptin Levels in Women with Polycystic Ovary Syndrome: The Role of Insulin Resistance/ , 2022 .

[16]  W. Walters,et al.  Arterial reactivity is enhanced in genetic males taking high dose estrogens. , 1997, Journal of the American College of Cardiology.

[17]  R. Huupponen,et al.  Serum leptin concentrations in women with polycystic ovary syndrome. , 1997, The Journal of clinical endocrinology and metabolism.

[18]  C. Christiansen,et al.  Tibolone: influence on markers of cardiovascular disease. , 1997, The Journal of clinical endocrinology and metabolism.

[19]  A. Rigotti,et al.  Scavenger receptor BI--a cell surface receptor for high density lipoprotein. , 1997, Current opinion in lipidology.

[20]  H. Perry,et al.  Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. , 1997, The Journal of clinical endocrinology and metabolism.

[21]  G. New,et al.  Long-term estrogen therapy improves vascular function in male to female transsexuals. , 1997, Journal of the American College of Cardiology.

[22]  C. Mantzoros,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Leptin Concentrations in the Polycystic Ovary Syndrome* , 2022 .

[23]  R. Vogel.  Coronary risk factors, endothelial function, and atherosclerosis: A review , 1997, Clinical cardiology.

[24]  C. Glueck,et al.  Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. , 1997, Metabolism: clinical and experimental.

[25]  H. White,et al.  Association between Polycystic Ovaries and Extent of Coronary Artery Disease in Women Having Cardiac Catheterization , 1997, Annals of Internal Medicine.

[26]  G. B. Phillips,et al.  Relationship Between Serum Sex Hormones and Coronary Artery Disease in Postmenopausal Women , 1997 .

[27]  Y. Ouchi,et al.  Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. , 1997, Atherosclerosis.

[28]  F. Lönnqvist,et al.  Role of leptin and its receptor in human obesity , 1997 .

[29]  P. Halushka,et al.  Gender-related differences in androgen regulation of thromboxane A2 receptors in rat aortic smooth-muscle cells. , 1997, Journal of cardiovascular pharmacology.

[30]  S. Glantz,et al.  Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. , 1997, Journal of the American College of Cardiology.

[31]  M. Charles,et al.  Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. , 1997, The Journal of clinical endocrinology and metabolism.

[32]  G. Vogel.  Leptin: A Trigger for Puberty? , 1996, Science.

[33]  K. Chatterjee,et al.  Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. , 1996, Circulation.

[34]  M. Sampson,et al.  Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI‐1) activity in lean women with and without the polycystic ovary syndrome , 1996, Clinical endocrinology.

[35]  G. Zimmerman,et al.  Adhesion and signaling in vascular cell-cell interactions. , 1996, The Journal of clinical investigation.

[36]  G. Zimmerman,et al.  Perspectives series: Cell adhesion in vascular biology. Adhesion and signaling in vascular cell-cell interactions , 1996 .

[37]  A. von Eckardstein,et al.  Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome. , 1996, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[38]  P. Milos,et al.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Tchernof,et al.  Obesity and metabolic complications: contribution of dehydroepiandrosterone and other steroid hormones. , 1996, The Journal of endocrinology.

[40]  E. Bolu,et al.  Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism. , 1996, The Journal of clinical endocrinology and metabolism.

[41]  C. Christiansen,et al.  The relationship of natural androgens to coronary heart disease in males: a review. , 1996, Atherosclerosis.

[42]  E. Smith.  Haemostatic factors and atherogenesis. , 1996, Atherosclerosis.

[43]  S. Potter.  Soy protein and serum lipids , 1996, Current opinion in lipidology.

[44]  U. Winkler.  Effects of androgens on haemostasis , 1996 .

[45]  A. Jungwirth,et al.  Treatment of prostate cancer with gonadotropin-releasing hormone analogue: effect on lipoprotein[a]. , 1996, The Journal of clinical endocrinology and metabolism.

[46]  M. Eriksson,et al.  Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males. , 1996, The Journal of clinical endocrinology and metabolism.

[47]  P. Thompson,et al.  Testosterone decreases lipoprotein(a) in men. , 1996, The American journal of cardiology.

[48]  A. von Eckardstein,et al.  Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. , 1996, The American journal of cardiology.

[49]  S. Miura,et al.  Inhibition of cholesterylester accumulation by 17 beta-estradiol in macrophages through activation of neutral cholesterol esterase. , 1996, Biochimica et biophysica acta.

[50]  R. Busse,et al.  Endothelial dysfunction in atherosclerosis. , 1996, Journal of vascular research.

[51]  G. Lippi,et al.  Testosterone-induced suppression of lipoprotein(a) in normal men; relation to basal lipoprotein(a) level. , 1996, Atherosclerosis.

[52]  G. Dagenais,et al.  Hyperinsulinemia as an independent risk factor for ischemic heart disease. , 1996, The New England journal of medicine.

[53]  S. Marcovina,et al.  Molecular biology of phospholipid transfer protein , 1996, Current opinion in lipidology.

[54]  N. Sugino,et al.  Changes in interleukin-1 production of peritoneal macrophages during estrous cycle in golden hamsters. , 1996, Endocrine journal.

[55]  I. Goldberg.  Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. , 1996, Journal of lipid research.

[56]  L. Kuller,et al.  Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. , 1996, American journal of obstetrics and gynecology.

[57]  F. Whittier,et al.  Testosterone causes direct relaxation of rat thoracic aorta. , 1996, The Journal of pharmacology and experimental therapeutics.

[58]  P. Björntorp.  The regulation of adipose tissue distribution in humans. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[59]  W. Zgliczyński,et al.  Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men. , 1996, Atherosclerosis.

[60]  R. Virmani,et al.  Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. , 1996, The American journal of pathology.

[61]  R. Alexander,et al.  Endothelial control of the cardiovascular system: recent advances , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  A. Vermeulen.  Decreased androgen levels and obesity in men. , 1996, Annals of medicine.

[63]  R. Atkins,et al.  Secretion of bioactive interleukin 1 by rat testicular macrophages in vitro. , 1996, Journal of andrology.

[64]  E. Barrett-Connor,et al.  Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women , 1995, BMJ.

[65]  W. Bremner,et al.  Androgen and progestagen effects on plasma lipids. , 1995, Progress in cardiovascular diseases.

[66]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[67]  I. Tabas.  The stimulation of the cholesterol esterification pathway by atherogenic lipoproteins in macrophages , 1995, Current opinion in lipidology.

[68]  W. Bremner,et al.  Testosterone enanthate at a dose of 200 mg/week decreases HDL-cholesterol levels in healthy men. , 1995, International journal of andrology.

[69]  T. Olivecrona,et al.  Triglyceride lpases and atherosclerosis , 1995 .

[70]  T D Bjornsson,et al.  The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones. , 1995, American journal of obstetrics and gynecology.

[71]  R. Anderson,et al.  Haemostatic Effects of Supraphysiological Levels of Testosterone in Normal Men , 1995, Thrombosis and Haemostasis.

[72]  V. Maher,et al.  Lipoprotein (a) and coronary heart disease. , 1995, Current opinion in lipidology.

[73]  P. Urdal,et al.  Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia. , 1995, The Journal of urology.

[74]  G. Owens,et al.  Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.

[75]  L. Kuller,et al.  Coronary heart disease risk factors in women with polycystic ovary syndrome. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[76]  P. Libby.  Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[77]  F. Sacks,et al.  Sex hormones, lipoproteins, and vascular reactivity , 1995, Current opinion in lipidology.

[78]  E. Barrett-Connor,et al.  Testosterone and risk factors for cardiovascular disease in men. , 1995, Diabete & metabolisme.

[79]  M. Adams,et al.  Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[80]  K. Birkeland,et al.  Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome , 1995 .

[81]  K. Frazer,et al.  The apolipoprotein(a) gene is regulated by sex hormones and acute–phase inducers in YAC transgenic mice , 1995, Nature Genetics.

[82]  S. Thompson,et al.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.

[83]  T. Saruta,et al.  Up‐regulation of nitric oxide synthase by estradiol in human aorticendothelial cells , 1995, FEBS letters.

[84]  P. Ramwell,et al.  Effect of Testosterone Treatment on Vasoconstrictor Response of Left Anterior Descending Coronary Artery in Male and Female Pigs , 1995, Journal of cardiovascular pharmacology.

[85]  P. Poole‐Wilson,et al.  Testosterone relaxes rabbit coronary arteries and aorta. , 1995, Circulation.

[86]  R. Pasquali,et al.  Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. , 1995, The Journal of clinical endocrinology and metabolism.

[87]  S. Haffner,et al.  Endogenous sex hormones: impact on lipids, lipoproteins, and insulin. , 1995, The American journal of medicine.

[88]  E. Topol,et al.  Cell adhesion molecules in coronary artery disease. , 1994, Journal of the American College of Cardiology.

[89]  J. Manson,et al.  Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians: a prospective study. , 1994, American journal of epidemiology.

[90]  S. Johansson,et al.  Hemostatic and metabolic variables in women with polycystic ovary syndrome , 1994 .

[91]  V. Fuster,et al.  Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. , 1994, Circulation.

[92]  C. Berne,et al.  Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables , 1994, Clinical endocrinology.

[93]  J. Heiman,et al.  Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. , 1994, The Journal of clinical endocrinology and metabolism.

[94]  J. Després,et al.  Relation of components of insulin resistance syndrome to coronary disease risk. , 1994, Current opinion in lipidology.

[95]  Arai Hiroyuki,et al.  Structure-specific inhibition of lysosomal cholesterol transport in macrophages by various steroids. , 1994 .

[96]  J. Nauta,et al.  Serum testosterone level is the major determinant of the male-female differences in serum levels of high-density lipoprotein (HDL) cholesterol and HDL2 cholesterol. , 1994, Metabolism: clinical and experimental.

[97]  P. Deurenberg,et al.  Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. , 1994, The Journal of clinical endocrinology and metabolism.

[98]  F. Sacks,et al.  Sex hormones and lipoprotein metabolism. , 1994, Current opinion in lipidology.

[99]  G. B. Phillips,et al.  The association of hypotestosteronemia with coronary artery disease in men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[100]  S. Eisenberg,et al.  Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[101]  E. Nieschlag,et al.  Sustained suppression of serum LH, FSH and testosterone and increase of high‐density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men , 1994, Clinical endocrinology.

[102]  R. Lobo.  Treatment of the postmenopausal woman: Basic and clinical aspects Edited by R. A. Lobo. Published 1993 by Raven Press, New York. 463 pp. ISBN: 0-7817-0113-9. Price: US$174.00 , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[103]  Per Björntorp MD PhD FRCP EDIN,et al.  Hyperandrogenicity in women—a prediabetic condition? , 1993 .

[104]  M. Alessi,et al.  Fibrinolysis and atherothrombosis , 1993 .

[105]  T. Lüscher.  The endothelium as a target and mediator of cardiovascular disease , 1993, European journal of clinical investigation.

[106]  C. Glueck,et al.  Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men. , 1993, The Journal of laboratory and clinical medicine.

[107]  A. Tall.  Plasma cholesteryl ester transfer protein. , 1993, Journal of lipid research.

[108]  P. Poole‐Wilson,et al.  Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease , 1993, The Lancet.

[109]  L. Sjöström,et al.  Androgen treatment of abdominally obese men. , 1993, Obesity research.

[110]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[111]  E. Ernst,et al.  Fibrinogen as a Cardiovascular Risk Factor , 1993, Annals of Internal Medicine.

[112]  K. Frayn.  Insulin resistance and lipid metabolism , 1993 .

[113]  Weng Xz,et al.  Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients. , 1993 .

[114]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[115]  G. B. Phillips,et al.  Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[116]  P. Thompson,et al.  The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity. , 1993, Metabolism: clinical and experimental.

[117]  J. Yarnell,et al.  Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[118]  B. Nordestgaard,et al.  Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels. , 1993, Atherosclerosis.

[119]  G. Conway,et al.  Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin , 1993, Clinical endocrinology.

[120]  W. A. Bradley,et al.  Triglyceride, high density lipoprotein, and coronary heart disease. , 1993, Consensus statement. National Institutes of Health Consensus Development Conference.

[121]  A. Wechsler,et al.  Inhibition of Accelerated Coronary Atherosclerosis With Dehydroepiandrosterone in the Heterotopic Rabbit Model of Cardiac Transplantation , 1993, Circulation.

[122]  L. Sjöström,et al.  The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[123]  S. Johansson,et al.  Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women , 1992, Acta obstetricia et gynecologica Scandinavica.

[124]  A. LaCroix,et al.  Dehydroepiandrosterone Sulfate, Incidence of Myocardial Infarction, and Extent of Atherosclerosis in Men , 1992, Circulation.

[125]  S. Johansson,et al.  Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long‐term follow‐up focusing on natural history and circulating hormones , 1992 .

[126]  G. Conway,et al.  Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome , 1992, Clinical endocrinology.

[127]  E. Boerwinkle,et al.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.

[128]  W. Vale,et al.  Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels. , 1992, Annals of internal medicine.

[129]  B. Angelin,et al.  Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. , 1992, The Journal of clinical investigation.

[130]  P. Björntorp,et al.  Effect of testosterone on abdominal adipose tissue in men. , 1991, International journal of obesity.

[131]  R. Lobo,et al.  Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. , 1991, The Journal of clinical endocrinology and metabolism.

[132]  E. Krul,et al.  In vivo regulation of apolipoprotein A-I gene expression by estradiol and testosterone occurs by different mechanisms in inbred strains of mice. , 1991, Journal of lipid research.

[133]  P. Halushka,et al.  Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells. , 1991, Circulation research.

[134]  A. Jonas.  Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. , 1991, Biochimica et biophysica acta.

[135]  E. Barrett-Connor,et al.  Estrogen and coronary heart disease in women , 1991, JAMA.

[136]  T. O'Brien,et al.  Relation of serum testosterone levels to high density lipoprotein cholesterol and other characteristics in men. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[137]  G Lindstedt,et al.  Low Sex-Hormone-Binding Globulin Concentration as Independent Risk Factor for Development of NIDDM: 12-Yr Follow-Up of Population Study of Women in Gothenburg, Sweden , 1991, Diabetes.

[138]  J. Fleg,et al.  Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men. , 1990, Journal of andrology.

[139]  L. Sjöström,et al.  Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. , 1990, Metabolism: clinical and experimental.

[140]  B. Grubb,et al.  Clinical signs of androgen excess as risk factors for coronary artery disease. , 1990, Fertility and sterility.

[141]  A. Dunaif,et al.  THE INDEPENDENT EFFECTS OF HYPERANDROGENAEMIA, HYPERINSULINAEMIA, AND OBESITY ON LIPID AND LIPOPROTEIN PROFILES IN WOMEN * , 1990 .

[142]  P. Caron,et al.  Plasminogen activator inhibitor in plasma is related to testosterone in men. , 1989, Metabolism: clinical and experimental.

[143]  M. Hromadová,et al.  Some measures of lipid metabolism in young sterile males before and after testosterone treatment. , 1989, Endocrinologia experimentalis.

[144]  D. Kiel,et al.  Sex hormones and lipoproteins in men. , 1989, The American journal of medicine.

[145]  S. Franks.  POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE , 1989, Clinical endocrinology.

[146]  R. Rosenfield,et al.  The polycystic ovary syndrome: pathogenesis and treatment. , 1989, Annals of internal medicine.

[147]  Y. Arad,et al.  Dehydroepiandrosterone Feeding Prevents Aortic Fatty Streak Formation and Cholesterol Accumulation in Cholesterol‐fed Rabbit , 1989, Arteriosclerosis.

[148]  P. Thompson,et al.  Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. , 1989, JAMA.

[149]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[150]  E. Barrett-Connor,et al.  Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. , 1988, Circulation.

[151]  H. Weisman,et al.  Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury. , 1988, The Journal of clinical investigation.

[152]  R. Mcnutt,et al.  Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. , 1988, The American journal of cardiology.

[153]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[154]  E. Nikkilä,et al.  Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males. , 1988, Atherosclerosis.

[155]  G. Reaven,et al.  Additive Hypoglycemic Effects of Drugs That Modify Free-Fatty Acid Metabolism by Different Mechanisms in Rats With Streptozocin-Induced Diabetes , 1988, Diabetes.

[156]  L. Kuller,et al.  Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. , 1987, The American journal of cardiology.

[157]  E. Barrett-Connor,et al.  Absence of an inverse relation of dehydroepiandrosterone sulfate with cardiovascular mortality in postmenopausal women. , 1987, The New England journal of medicine.

[158]  J. Probstfield,et al.  Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence. Correlation with plasma testosterone levels. , 1987, JAMA.

[159]  E. Barrett-Connor,et al.  A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. , 1986, The New England journal of medicine.

[160]  P. Puska,et al.  Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men. , 1986, Metabolism: clinical and experimental.

[161]  P. Coulson,et al.  Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. , 1985, The Journal of clinical endocrinology and metabolism.

[162]  L. Mattsson,et al.  Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. , 1984, Fertility and sterility.

[163]  J. Verheijen,et al.  Modulation of Rapid Plasminogen Activator Inhibitor in Plasma by Stanozolol , 1984, Thrombosis and Haemostasis.

[164]  T. Toda,et al.  Ultrastructural changes in the comb and aorta of chicks fed excess testosterone. , 1984, Atherosclerosis.

[165]  S. Kaplan,et al.  Insulin resistance in nonobese patients with polycystic ovarian disease. , 1983, The Journal of clinical endocrinology and metabolism.

[166]  J. Wortsman,et al.  Abnormalities of Fuel Metabolism in the Polycystic Ovary Syndrome , 1982, Obstetrics and gynecology.

[167]  M. Maxwell,et al.  The effect of weight loss on reproductive hormones in obese men. , 1981, The Journal of clinical endocrinology and metabolism.

[168]  D. Aharony,et al.  Testosterone Potentiation of Ionophore and ADP Induced Platelet Aggregation : Relationship to Arachidonic Acid Metabolism , 1981, Thrombosis and Haemostasis.

[169]  C. Glueck,et al.  Hypertriglyceridemia and hypoalphalipoproteinemia in azoospermic and oligospermic young men: relationships of endogenous testosterone to triglyceride and high density lipoprotein cholesterol metabolism. , 1981, Metabolism: clinical and experimental.

[170]  S. C. Yen,et al.  REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME , 1980 .

[171]  M. Jaffe.  Effect of testosterone cypionate on postexercise ST segment depression. , 1977, British heart journal.

[172]  C. Glueck,et al.  Effect of sex hormones on protamine inactivated and resistant postheparin plasma lipases. , 1976, Metabolism: clinical and experimental.

[173]  S. A. Levine,et al.  The Therapeutic Value of Testosterone Propionate in Angina Pectoris , 1943 .

[174]  M. A. Lesser.  The Treatment of Angina Pectoris with Testosterone Propionate: Further Observations , 1943 .

[175]  L. Hamm.  Testosterone Propionate in the Treatment of Angina Pectoris , 1942 .

[176]  M. A. Lesser.  The Treatment of Angina Pectoris with Testosterone Propionate: Preliminary Report , 1942 .

[177]  S. Haffner.  Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes. , 1996, Hormone research.

[178]  P. Björntorp,et al.  Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. , 1995, The Journal of clinical endocrinology and metabolism.

[179]  P. Urdal,et al.  Effects of the nonsteroidal antiandrogen Casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia. , 1995, European urology.

[180]  R. Ross,et al.  Cell biology of atherosclerosis. , 1995, Annual review of physiology.

[181]  A. Tall.  Plasma lipid transfer proteins. , 1995, Annual Review of Biochemistry.

[182]  A. Vermeulen,et al.  Ageing of the hypothalamo-pituitary-testicular axis in men. , 1995, Hormone research.

[183]  P. Björntorp.  Fatty acids, hyperinsulinemia, and insulin resistance: which comes first? , 1994, Current opinion in lipidology.

[184]  A. Hamsten,et al.  Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease. , 1994, Journal of internal medicine. Supplement.

[185]  J. Auwerx,et al.  Effects of sex steroids on hepatic and lipoprotein lipase activity and mRNA in the rat. , 1993, Hormone research.

[186]  B. McEwen,et al.  Non-genomic and genomic effects of steroids on neural activity. , 1991, Trends in pharmacological sciences.

[187]  Robert E. Jones,et al.  High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. , 1990, Metabolism: clinical and experimental.

[188]  P. Henriksson,et al.  Stanozolol and experimental atherosclerosis: atherosclerotic development and blood lipids during anabolic steroid therapy of New Zealand white rabbits. , 1990, Scandinavian journal of clinical and laboratory investigation.

[189]  K. Yano,et al.  Serum sex hormone levels and myocardial infarction in the Honolulu Heart Program. Pitfalls in prospective studies on sex hormones. , 1988, Journal of clinical epidemiology.

[190]  A. Dunaif,et al.  The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. , 1988, The Journal of clinical endocrinology and metabolism.

[191]  P. Caron,et al.  Plasma fibrinolytic activity in a group of hypogonadic men. , 1987, Scandinavian journal of clinical and laboratory investigation.

[192]  J. Cortés-Prieto.  Coagulation and fibrinolysis in post-menopausal women treated with Org OD 14. , 1987, Maturitas.

[193]  G. Getz,et al.  Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B. , 1985, The Journal of clinical endocrinology and metabolism.